“Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.”

AUTHORS: Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R.

Nat Med. 2019 Feb 11. doi: 10.1038/s41591-019-0349-y.

Previous
Previous

“arcasHLA: high resolution HLA typing from RNAseq.”

Next
Next

“Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.”